(Sharecast News) - AstraZeneca has announced positive high-level results from a phase III for its Texspire treatment for nasal polyps.
The company said results from the WAYPOINT trial, which evaluated the efficacy and safety of Tezspire (otherwise known as tezepelumab) compared to a placebo in adults with severe chronic rhinosinusitis with...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE